Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.1 (
RNase
)
16,360
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently, a new member of aquaporins was reported as
AQP10
[Biochem. Biophys. Res. Commun. 287 (2001) 814], which is incompletely spliced to lose the sixth transmembrane domain and has poor water and no glycerol/urea permeabilities. Independently, we identified a similar clone in human. Our
AQP10
consists of 301 amino acids with a highly conserved sixth transmembrane domain.
AQP10
has higher identity with aquaglyceroporins (50% with AQP9, 48% with AQP3, 42% with AQP7) and lower identity with other aquaporins (32% with AQP1 and AQP8).
AQP10
is expressed only in the small intestine with (approximately 2 kb).
RNase
protection assay revealed the absence of the unspliced form, supporting the authenticity of our clone. When expressed in Xenopus oocytes,
AQP10
stimulated osmotic water permeability sixfold in a mercury-sensitive manner. Glycerol and urea uptakes were also stimulated, while adenine uptake was not. The genome structure of
AQP10
is similar to those of other aquaglyceroporins (AQP3, AQP7, AQP9) with six exons. We conclude that
AQP10
represents a new member of aquaglyceroporins functionally as well as structurally.
...
PMID:Cloning and identification of a new member of water channel (AQP10) as an aquaglyceroporin. 1208 81